BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 20601792)

  • 1. Trends in Salmonella enteric serovar Typhi in Nairobi, Kenya from 2004 to 2006.
    Mengo DM; Kariuki S; Muigai A; Revathi G
    J Infect Dev Ctries; 2010 Jun; 4(6):393-6. PubMed ID: 20601792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing trends in antimicrobial resistance of Salmonella enterica serovar typhi and salmonella enterica serovar paratyphi A in Chennai.
    Krishnan P; Stalin M; Balasubramanian S
    Indian J Pathol Microbiol; 2009; 52(4):505-8. PubMed ID: 19805957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug resistance in Salmonella enterica serovar typhi isolated from patients with typhoid fever complications in Lagos, Nigeria.
    Akinyemi KO; Smith SI; Oyefolu AO; Coker AO
    Public Health; 2005 Apr; 119(4):321-7. PubMed ID: 15733694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in minimum inhibitory concentration to quinolones and ceftriaxone in salmonellae causing enteric fever.
    Sekar U; Srikanth P; Kindo AJ; Babu VP; Ramasubramanian V
    J Commun Dis; 2003 Sep; 35(3):162-9. PubMed ID: 15796408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence and properties of fluoroquinolone resistant Salmonella enterica serovar Typhi strains isolated from Nepal in 2002 and 2003.
    Nobthai P; Serichantalergs O; Wongstitwilairoong B; Srijan A; Bodhidatta L; Malla S; Mason CJ
    Southeast Asian J Trop Med Public Health; 2010 Nov; 41(6):1416-22. PubMed ID: 21329318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-drug resistant Salmonella enterica serovar Typhi isolates with reduced susceptibility to ciprofloxacin in Kenya.
    Mutai WC; Muigai AWT; Waiyaki P; Kariuki S
    BMC Microbiol; 2018 Nov; 18(1):187. PubMed ID: 30428828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of multidrug-resistant Salmonella enterica serovar Typhi with reduced susceptibility to fluoroquinolones in Cambodia.
    Kasper MR; Sokhal B; Blair PJ; Wierzba TF; Putnam SD
    Diagn Microbiol Infect Dis; 2010 Feb; 66(2):207-9. PubMed ID: 19800753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Salmonella Paratyphi A enteric fever and changing trends in antimicrobial resistance pattern of salmonella in Shimla.
    Verma S; Thakur S; Kanga A; Singh G; Gupta P
    Indian J Med Microbiol; 2010; 28(1):51-3. PubMed ID: 20061765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009.
    Menezes GA; Harish BN; Khan MA; Goessens WH; Hays JP
    Clin Microbiol Infect; 2012 Mar; 18(3):239-45. PubMed ID: 21714829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi.
    Agrawal P; Kapila K; Kumar S; Ghosh AN; Maurya AK
    Indian J Pathol Microbiol; 2010; 53(3):509-12. PubMed ID: 20699513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of gentamicin and amikacin against Salmonella enterica serovar Typhi: a search for a treatment regimen for typhoid fever.
    Mandal S; Mandal MD; Pal NK
    East Mediterr Health J; 2009; 15(2):264-8. PubMed ID: 19554971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of typhoid and paratyphoid fever in Kathmandu: two years study and trends of antimicrobial resistance.
    Malla S; Kansakar P; Serichantalergs O; Rahman M; Basnet S
    JNMA J Nepal Med Assoc; 2005; 44(157):18-22. PubMed ID: 16082406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug-resistant Salmonella enterica serovar typhi isolates with high-level resistance to ciprofloxacin in Dhaka, Bangladesh.
    Ahmed D; D'Costa LT; Alam K; Nair GB; Hossain MA
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3516-7. PubMed ID: 17005846
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of enteric fever in children on the basis of current trends of antimicrobial susceptibility of Salmonella enterica serovar typhi and paratyphi A.
    Manchanda V; Bhalla P; Sethi M; Sharma VK
    Indian J Med Microbiol; 2006 Apr; 24(2):101-6. PubMed ID: 16687859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
    Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B
    BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Typhoid fever: narrowing therapeutic options in India.
    Capoor MR; Nair D; Hasan AS; Aggarwal P; Gupta B
    Southeast Asian J Trop Med Public Health; 2006 Nov; 37(6):1170-4. PubMed ID: 17333772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current pattern in antimicrobial susceptibility of Salmonella Typhi isolates in Pondicherry.
    Madhulika U; Harish BN; Parija SC
    Indian J Med Res; 2004 Aug; 120(2):111-4. PubMed ID: 15347861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance of Salmonella enterica serovars Typhi and Typhimurium isolated from clinical samples at two rural hospitals in Western Kenya.
    Onyango D; Machioni F; Kakai R; Waindi EN
    J Infect Dev Ctries; 2008 Apr; 2(2):106-11. PubMed ID: 19738333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-level quinolone-resistance in multi-drug resistant typhoid.
    Mirza SH; Khan MA
    J Coll Physicians Surg Pak; 2008 Jan; 18(1):13-6. PubMed ID: 18452661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
    Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
    J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.